Addiction Medicine Made Easy | Fighting back against addiction – Détails, épisodes et analyse

Dr. Casey Grover breaks down psychiatric medications and their role in addiction treatment, explaining how different medications work, when they're most appropriate, and which ones to avoid. He provides a practical overview based on his extensive experience treating patients with substance use disorders.

• Psychiatric medications get developed through research on brain receptors and undergo rigorous testing before FDA approval
• Medications often have "off-label" uses that weren't originally intended but provide benefits in certain situations
• Antidepressants like SSRIs and SNRIs serve as the foundation for treating depression in people with addiction
• Using non-addictive options like hydroxyzine, clonidine, and buspirone is crucial when treating anxiety in recovery
• Trazodone and mirtazapine are preferred for sleep issues over benzodiazepines and "Z-drugs" that can create dependence
• ADHD treatment requires careful consideration when patients have stimulant use disorder histories
• Benzodiazepines should be avoided when possible as they paradoxically worsen anxiety over time
• Medication selection should consider urgency of conditions, past medication responses, and potential side effects
• Some psychiatric conditions may improve with therapy allowing medication reduction, while others require long-term treatment

Thank you for taking the time to learn about addiction. It's a fight we cannot win without awareness and action. There's still so much we can do to improve how addiction is treated. Together we can make it happen. Remember, treating addiction saves lives.

To contact Dr. Grover: ammadeeasy@fastmail.com

Kyle Santoro, a 19-year-old filmmaker, created the documentary "Fentanyl High" to explore teenage psychology behind substance abuse after witnessing overdoses at his high school. His film takes a peer-to-peer approach to addiction education, removing stigma and creating spaces for vulnerable conversations about why teens turn to substances.

Kyle and Dr Grover discuss his experiences making the film and what he has learned through making it:

• Kyle began the project after a classmate overdosed in a school bathroom and administrators never acknowledged the incident
• Traditional school responses to substance use often involve punishment and shame rather than compassion and understanding
• Several teens who participated in making the documentary achieved sobriety through the therapeutic process of sharing their stories
• Film screenings serve as community events with resources, panel discussions, and free naloxone distribution
• Schools often resist hosting screenings due to fear of being labeled as having a drug problem
• The documentary has been screened across multiple states creating a "domino effect" of awareness in communities
• Kyle raised $75,000 to produce the film through community sponsors and organizations
• Prevention efforts need more youth representation to create effective messaging that resonates with teens
• The film emphasizes the importance of parents maintaining open communication with their teenagers

If you want to learn more about Kyle's film, visit fentanylhigh.com.

To contact Dr. Grover: ammadeeasy@fastmail.com

This episode provides a deep dive into the complexities of addiction medicine learned from seeing patients in my practice. Through real patient cases, I highlight the importance of tailored approaches to addiction that consider both the physiological and psychological aspects of recovery.

We discuss
• Insights into demographics of substance use in a rural setting 
• The effectiveness of dual medication therapies for alcohol use disorder 
• The link between trauma and substance use disorders 
• Emerging concerns surrounding kratom as a public health issue 
• The significance of managing co-occurring ADHD in addiction treatment

To contact Dr. Grover: ammadeeasy@fastmail.com

Sure...you ask your patients if they vape, but how much do you know about the world of vaping? Are they using a cigalike, a vape pen, or a JUUL? And are they using standard cartridges or have they bought a custom vape juice? What types of vape juice are most associated with EVALI? In this episode we review vaping - the history of the industry, the health effects, and the societal trends. 

In this episode we take a very deep dive into the topic of illicit fentanyl. We review the history of the opiate epidemic in the United States that has led us to our current time where 100,000 Americans have died of a drug overdose in the past year. And more importantly, we discuss what we as healthcare providers can do to fight back against this crisis of illicit fentanyl (and worse) in our drug supply causing so many fatal overdoses. 

When was the last time you used phenobarbital for alcohol withdrawal? How familiar are you with how to dose it and when to give it? It turns out that phenobarbital is as effective as benzodiazepines for alcohol withdrawal, and might be a medication that you want to consider using in your practice for alcohol withdrawal. In this episode we dive into the topic of phenobarbital for alcohol withdrawal and try to figure out what's the best way to use phenobarbital when treating patients with alcohol withdrawal.

What does it mean to be well? In this episode we dig into the perspective of a person living with an opiate use disorder. Dr. Grover reads a piece on opiate addiction that he wrote with a patient who has lived experience with an opiate use disorder. The original article can be found here https://www.kevinmd.com/blog/2017/03/mean-well-ask-opiate-addict.html 

Has this ever happened to you at 11 pm on a Saturday Night..."Hey doc, I'm on 85 mg of methadone and I missed my daily dose yesterday. Can you give me a dose?" In Episode 19 we discuss methadone, how methadone is regulated, and what to do when a patient on methadone for OUD presents to the ED asking for a missed dose or needs inpatient admission.

In this episode, we review Post Acute Withdrawal Syndrome (PAWS). Haven't heard of it? You're not alone. It's a common, yet understudied syndrome experienced by people in early recovery. Unfortunately the data is limited, but Dr. Grover summarizes the best information we have on PAWS including pathophysiology, naming, symptoms, and treatment. 

Buprenorphine precipitated opiate withdrawal is the worst! Patients feel awful, and we as healthcare providers feel awful for making them feel awful. In this episode we review the literature on and discuss some local expert opinion on buprenorphine precipitated opiate withdrawal, including the best way to treat it if it happens.